IFHNOS Society Panel: The role of postoperative adjuvant therapies in early stage Oral cancer
09-11, 15:00–16:00 (Europe/Istanbul), Head & Neck Oncology 1

<p></p>
<p></p>
Moderator Moderator
<p>Dr. Sefik Hosal is currently Professor at the Department of Otolaryngology - Head and Neck Surgery, Atilim University Faculty of Medicine, Ankara, Turkey.</p> <p>Prof. A. Sefik Hosal (M.D.) received his medical degree from Hacettepe University Medical Faculty, Ankara, Turkey. He completed his training in Otorhinolaryngology at the same University. He became a Professor in 2003 at the Department of Otolaryngology - Head and Neck Surgery in Hacettepe University Faculty of Medicine.</p> <p>Dr. Sefik Hosal did his postgraduate training as a research fellow at Mount Sinai Hospital, University of Toronto, Canada. He did his clinical fellowship as a visiting instructor at University of Pittsburgh Medical Center, USA.</p> <p>He has more than 100 national and international publications. He is the pioneer of “Multidisciplinary Team Work in head & neck cancer” in Turkey. He is the founder and General secretary of “Head and Neck Cancer Society of Turkey”. He was an Executive Council Member of International Federation of Head and Neck Oncologic Societies (IFHNOS) (2018-2022) and current member of IFHNOS ’Masters in Head and Surgery’ section. He is an Executive Council Member of Asia-Pacific Society of Thyroid Surgery (APTS) (2018-2022, 2022-2026). Prof. Hosal is currently General Secretary of European Head & Neck Society (EHNS).</p>
This speaker also appears in:
<p>Ehab Hanna, M.D., FACS, is an internationally recognized head and neck surgeon and expert in the treatment of patients with skull base tumors and head and neck cancer. Dr. Hanna is currently a Professor and Vice Chair of the Department of Head and Neck Surgery with a joint appointment in the Department of Neurosurgery, MD Anderson Cancer Center. He also serves as an Adjunct Professor of Otolaryngology and Head and Neck Surgery at Baylor College of Medicine. He served as the medical director of the Multidisciplinary Head and Neck Center for 20 years (2004-2023) and is currently the director of the Skull Base Tumor program. For the last 15 years, Dr. Hanna has consistently been named one of America's Best Doctors and Top Doctors in Cancer. In addition to patient care, Dr. Hanna is actively engaged in clinical and translational research with emphasis on skull base tumors. He authored over 350 publications, invited articles, book chapters, and editorials. He co-edited several major textbooks on Cancer of the Head and Neck, Cancer of the Larynx, and Comprehensive Management of Skull Base Tumors. He served as the Editor-in-Chief of the journal of Head & Neck for 15 years from 2007 to 2022. Dr. Hanna served as the President of the North American Skull Base Society (2013-2014) and the President of the American Head and Neck Society (2018-2019). He is currently the Secretary General of the International Federation of Head & Neck Oncologic Societies, the largest organization in the world for Head and Neck Oncology.</p>
This speaker also appears in:
<p></p>